AmoyDx Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 1,175

Employees

  • Stock Symbol
  • 300685

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $2.73
  • (As of Friday Closing)

AmoyDx General Information

Description

Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.

Contact Information

Website
www.amoydx.com
Formerly Known As
Xiamen Aide Biotechnology
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Number 39 Dingshan Road, Haicang District
  • Xiamen, Fujian 361000
  • China
+86 0592
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Diagnostic Equipment
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • Number 39 Dingshan Road, Haicang District
  • Xiamen, Fujian 361000
  • China
+86 0592

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AmoyDx Stock Performance

As of 13-Nov-2026, AmoyDx’s stock price is $2.73. Its current market cap is $1.06B with 390M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.73 $2.85 $2.30 - $3.50 $1.06B 390M 10M $0.13

AmoyDx Financials Summary

As of 30-Sep-2026, AmoyDx has a trailing 12-month revenue of $174M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,088,299 971,507 1,103,287 1,116,343
Revenue 174,370 166,553 154,547 147,495
EBITDA 53,558 60,773 44,668 47,128
Net Income 50,188 50,235 35,519 36,960
Total Assets 336,452 335,535 282,846 272,957
Total Debt 25,095 15,522 7,843 7,996
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AmoyDx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AmoyDx‘s full profile, request access.

Request a free trial

AmoyDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnos
Biotechnology
Xiamen, China
1,175 As of 2025

Hercules, CA
 

Louisville, CO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AmoyDx Competitors (12)

One of AmoyDx’s 12 competitors is Bio-Rad Laboratories, a Corporation company based in Hercules, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bio-Rad Laboratories Corporation Hercules, CA
Biodesix Formerly VC-backed Louisville, CO
Coyote Bioscience Co., Ltd. Venture Capital-Backed Beijing, China
Insight Molecular Diagnostics Formerly VC-backed Nashville, TN
Indivumed Therapeutics Private Debt Financed Hamburg, Germany
You’re viewing 5 of 12 competitors. Get the full list »

AmoyDx Patents

AmoyDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025140181-A1 Method for simultaneously analyzing genetic information and epigenetic information Inactive 28-Dec-2023
EP-4328920-A1 Microsatellite instability detection method based on second-generation sequencing Pending 20-Apr-2021
EP-4328920-A4 Microsatellite instability detection method based on second-generation sequencing Pending 20-Apr-2021
WO-2022222668-A1 Microsatellite instability detection method based on second-generation sequencing Inactive 20-Apr-2021
WO-2022161272-A1 Biomarker group for detecting population microsatellite instability, and application of biomarker group Inactive 27-Jan-2021 C12Q1/6888
To view AmoyDx’s complete patent history, request access »

AmoyDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AmoyDx Investments (2)

AmoyDx’s most recent deal was a Early Stage VC with Salus BioMed for . The deal was made on 10-Oct-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Salus BioMed 10-Oct-2025 Early Stage VC Diagnostic Equipment
Universal Sequencing Technology 24-May-2018 Early Stage VC Discovery Tools (Healthcare)
To view AmoyDx’s complete investments history, request access »

AmoyDx ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

23.28 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 67

Rank

Percentile

To view AmoyDx’s complete esg history, request access »

AmoyDx FAQs

  • When was AmoyDx founded?

    AmoyDx was founded in 2008.

  • Where is AmoyDx headquartered?

    AmoyDx is headquartered in Xiamen, China.

  • What is the size of AmoyDx?

    AmoyDx has 1,175 total employees.

  • What industry is AmoyDx in?

    AmoyDx’s primary industry is Biotechnology.

  • Is AmoyDx a private or public company?

    AmoyDx is a Public company.

  • What is AmoyDx’s stock symbol?

    The ticker symbol for AmoyDx is 300685.

  • What is the current stock price of AmoyDx?

    As of 13-Nov-2026 the stock price of AmoyDx is $2.73.

  • What is the current market cap of AmoyDx?

    The current market capitalization of AmoyDx is $1.06B.

  • What is AmoyDx’s current revenue?

    The trailing twelve month revenue for AmoyDx is $174M.

  • Who are AmoyDx’s competitors?

    Bio-Rad Laboratories, Biodesix, Coyote Bioscience Co., Ltd., Insight Molecular Diagnostics, and Indivumed Therapeutics are some of the 12 competitors of AmoyDx.

  • What is AmoyDx’s annual earnings per share (EPS)?

    AmoyDx’s EPS for 12 months was $0.13.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process